Basic Information
| LncRNA/CircRNA Name | NCRNA00210 |
| Synonyms | LINC00210, NCRNA00210 |
| Region | GRCh38_1:217892900-217920804 |
| Ensemble | ENSG00000231814 |
| Refseq | NR_048550 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | Microarray, qPCR, RNAi, Western blot etc. |
| Sample | cell lines (A549, CDDP etc.) |
| Expression Pattern | up-regulated |
| Function Description | For lncRNA, the results showed that AK123263, CES1P1-001, RP3-508I15.14, AK126698, TP53TG1, and AC090952.4.1 decreased, whereas uc003bgl.1 and NCRNA00210 increased in A549/CDDP. Cisplatin resistance in non-small-cell lung cancer cells may relate to the changes in noncoding RNAs. Among these, AK126698 appears to confer cisplatin resistance by targeting the Wnt pathway. |
| Pubmed ID | 23741487 |
| Year | 2013 |
| Title | The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. |
External Links
| Links for NCRNA00210 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |